In this retrospective study, the efficacy and safety were examined for an intraperitoneal chemotherapy protocol- @entity786 , @entity1891 and @entity617 ( @entity7173 -COP) in 26 @entity468 with @entity706 . Certainly in @entity468 fiercely resisting IV administration the @entity7173 route is a more practical method, safer for the administrator and less stressful for the cat. Complete remission (CR) rate was 76.9% (n   =   20). Median duration of first remission was 421   days. Estimated 1- and 2-year disease free period were 67.1 and 48.0%, respectively. Median duration of survival was 388   days and estimated overall 1- and 2-year survival periods were 54.7 and 46.9% respectively. Young @entity468 had a more favourable prognosis. Reaching CR was essential for long-term survival. No specific @entity7173 -related adverse events (AE) were seen. AE were generally scored as mild and were not excessively abundant. These results indicate that the @entity7173 route is a safe and effective alternative for the administration of COP protocol chemotherapeutics.

Intraperitoneal antineoplastic drug delivery: experience with a @entity786 , @entity1891 and XXXX protocol in @entity468 with @entity706 .

@entity706 :: ('MESH:D008223', 'Disease') :: ['malignant lymphoma'] @entity786 :: ('MESH:D003520', 'Chemical') :: ['cyclophosphamide'] @entity1891 :: ('MESH:D014750', 'Chemical') :: ['vincristine'] @entity468 :: ('9685', 'Species') :: ['cats'] @entity7173 :: ('MESH:D007184', 'Disease') :: ['IP'] @entity617 :: ('MESH:D011239', 'Chemical') :: ['prednisolone']
@entity617 :: (MESH:D011239,Chemical) :: ['prednisolone']
